Genfit SA (GNFT)
5.76
-0.12
(-2.04%)
USD |
NASDAQ |
Nov 04, 16:00
5.76
0.00 (0.00%)
After-Hours: 20:00
Genfit Total Assets (Quarterly): 192.20M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 208.78M |
| December 31, 2023 | 192.20M |
| June 30, 2023 | 210.72M |
| December 31, 2022 | 231.15M |
| June 30, 2022 | 247.62M |
| December 31, 2021 | 318.97M |
| June 30, 2021 | 159.12M |
| December 31, 2020 | 243.68M |
| June 30, 2020 | 288.14M |
| December 31, 2019 | 347.09M |
| June 30, 2019 | 368.06M |
| June 30, 2019 | 368.06M |
| December 31, 2018 | 262.50M |
| June 30, 2018 | 304.82M |
| June 30, 2018 | 304.82M |
| December 31, 2017 | 351.73M |
| June 30, 2017 | 168.62M |
| June 30, 2017 | 168.62M |
| December 31, 2016 | 175.71M |
| June 30, 2016 | 119.90M |
| Date | Value |
|---|---|
| June 30, 2016 | 119.90M |
| December 31, 2015 | 75.72M |
| June 30, 2015 | 86.24M |
| June 30, 2015 | 86.24M |
| December 31, 2014 | 105.02M |
| June 30, 2014 | 104.90M |
| June 30, 2014 | 104.90M |
| December 31, 2013 | 40.25M |
| June 30, 2013 | 45.27M |
| June 30, 2013 | 45.27M |
| December 31, 2012 | 31.19M |
| June 30, 2012 | 32.17M |
| June 30, 2012 | 32.17M |
| December 31, 2011 | 37.66M |
| June 30, 2011 | 38.18M |
| June 30, 2011 | 38.18M |
| December 31, 2010 | 41.74M |
| June 30, 2010 | 42.60M |
| December 31, 2009 | 54.95M |
| June 30, 2009 | 59.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
159.12M
Minimum
Jun 2021
347.09M
Maximum
Dec 2019
244.75M
Average
237.41M
Median
Total Assets (Quarterly) Benchmarks
| Edap TMS SA | 88.07M |
| DBV Technologies SA | 114.19M |
| Cellectis SA | 407.15M |
| Ascendis Pharma AS | 812.82M |
| Adaptimmune Therapeutics PLC | 321.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 117.09M |
| Shareholders Equity (Quarterly) | 75.11M |
| Debt to Equity Ratio | 0.9462 |
| Current Ratio | 2.940 |
| Net Debt Paydown Yield | -6.06% |